Skip to content
Find a Provider
Samantha C. Heacock

Samantha C. Heacock

she/her/hers

Contact

Appointment (585) 598-8600
Office (585) 758-0750
Fax (585) 872-0876
Fax (585) 388-6393

About Me

Certified Specialties

Advanced Diabetes Management - Board Certified-Advanced Diabetes Management

Ambulatory Care Pharmacy - Board of Pharmacy Specialties

Credentials

Residency & Fellowship

PGY2 Ambulatory Care Pharmacy Residency: Highland Family Medicine and St. John Fisher College (American Society of Health-Systems Pharmacists Accredited) 2018 - 2019

PGY1 Community Pharmacy Residency: University of Rochester Medical Center (American Society of Health-Systems Pharmacists Accredited) 2017 - 2018

Education

PharmD | St. John Fisher College - Wegmans School of Pharmacy. 2017

Publications

Journal Articles

Real-world Impact of 3 and 4.5 mg Doses of Dulaglutide on Weight and Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus.

Duong A, Heacock S, Amering S, Brennan L, Venci J, Acquisto NM

The Annals of pharmacotherapy.. 2023 September 24 :10600280231199852. Epub 09/24/2023.

The Rochester Relapse Risk Scale: Developing a Standardized Approach to Predicting Substance Relapse in Liver Transplant Candidates.

Leistman SC, Melaragno JI, Dokus MK, Martens JA, Salter MA, Hutchinson DJ, Hernandez-Alejandro R, Al-Judaib B, Nickels MW

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.. 2021 September 19 (9):919-927. Epub 1900 01 01.

The Rochester Relapse Risk Scale: Developing a Standardized Approach to Predicting Substance Relapse in Liver Transplant Candidates

Leistman S; Iuppa-Melaragno J; Dokus K; Martens J; Salter M; Hutchinson D; Al-Judaibi B; Hernandez-Alejandro R; Nickels M.

Experimental and Clinical Transplantation. 2021; 19(9): 919-927.

A new spin on transitions of care: Pharmacists bridging the gap between inpatient and outpatient settings

Leistman, S; Nagel, A; Ahmed-Sarwar, N.

Journal of the American College of Clinical Pharmacy. 2020; 3(8): 1405-1412.

SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?

Ahmed-Sarwar N, Nagel AK, Leistman S, Heacock K

The Annals of pharmacotherapy.. 2017 September 51 (9):791-796. Epub 05/23/2017.